Attana receives an instrument order from global pharma company
Attana has received its first order for the newly launched Attana Cell™ 250 instrument. The order has been placed from an existing pharma customer headquartered in Europe and is the result of several successful contract research projects initiated in the spring of 2018.In March 2018, Attana announced the order of a smaller contract research project from a global pharma company. Following the success of several smaller research projects the customer has today placed an order for an Attana Cell™ 250 instrument. The order will affect the company’s cashflow and earnings in Q4 2020 and Q1 2021.